As a result, the AAV9-Sfrp1 viral vector improved cardiac systolic and diastolic functions via inhibiting Wnt pro-apoptotic signaling in myocardium from TAC mice. This evidence concerns the gene SFRP1 and persistent truncus arteriosus.